Fatourechi V - Search Results

1

Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers.

Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Bible KC, et al. Among authors: fatourechi v. Am J Manag Care. 2012 May 1;18(5):e162-7. Am J Manag Care. 2012. PMID: 22694109 Free article.

2

The glucagonoma syndrome. Clinical and pathologic features in 21 patients.

Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. Wermers RA, et al. Among authors: fatourechi v. Medicine (Baltimore). 1996 Mar;75(2):53-63. doi: 10.1097/00005792-199603000-00002. Medicine (Baltimore). 1996. PMID: 8606627 Free article.

3

Thyroglossal duct carcinoma: report of 12 cases.

Heshmati HM, Fatourechi V, van Heerden JA, Hay ID, Goellner JR. Heshmati HM, et al. Among authors: fatourechi v. Mayo Clin Proc. 1997 Apr;72(4):315-9. doi: 10.4065/72.4.315. Mayo Clin Proc. 1997. PMID: 9121176

4

Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance.

Fatourechi V, Hay ID. Fatourechi V, et al. Semin Nucl Med. 2000 Apr;30(2):107-14. doi: 10.1053/nm.2000.4600. Semin Nucl Med. 2000. PMID: 10787191 Review.

5

Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?

Fatourechi V, Hay ID, Mullan BP, Wiseman GA, Eghbali-Fatourechi GZ, Thorson LM, Gorman CA. Fatourechi V, et al. Thyroid. 2000 Jul;10(7):573-7. doi: 10.1089/thy.2000.10.573. Thyroid. 2000. PMID: 10958309

6

Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.

Fatourechi V, Hay ID, Javedan H, Wiseman GA, Mullan BP, Gorman CA. Fatourechi V, et al. J Clin Endocrinol Metab. 2002 Apr;87(4):1521-6. doi: 10.1210/jcem.87.4.8373. J Clin Endocrinol Metab. 2002. PMID: 11932275

7

de Quervain's thyroiditis: surgical experience.

Duininck TM, van Heerden JA, Fatourechi V, Curlee KJ, Farley DR, Thompson GB, Grant CS, Lloyd RV. Duininck TM, et al. Among authors: fatourechi v. Endocr Pract. 2002 Jul-Aug;8(4):255-8. doi: 10.4158/EP.8.4.255. Endocr Pract. 2002. PMID: 12173910

8

Effects of reducing the upper limit of normal TSH values.

Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC 3rd. Fatourechi V, et al. JAMA. 2003 Dec 24;290(24):3195-6. doi: 10.1001/jama.290.24.3195-b. JAMA. 2003. PMID: 14693871 No abstract available.

9

Primary squamous cell carcinoma of the thyroid: report of ten cases.

Booya F, Sebo TJ, Kasperbauer JL, Fatourechi V. Booya F, et al. Among authors: fatourechi v. Thyroid. 2006 Jan;16(1):89-93. doi: 10.1089/thy.2006.16.89. Thyroid. 2006. PMID: 16487020

10

Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.

Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V. Smallridge RC, et al. Among authors: fatourechi v. J Clin Endocrinol Metab. 2007 Jan;92(1):82-7. doi: 10.1210/jc.2006-0993. Epub 2006 Oct 31. J Clin Endocrinol Metab. 2007. PMID: 17077133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters